356 results on '"MacGowan, Alasdair P."'
Search Results
2. Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study
3. Clinical diagnosis and treatment of common respiratory tract infections in relation to microbiological profiles in rural health facilities in China: implications for antibiotic stewardship
4. Risk factors for hospital readmission following complicated urinary tract infection
5. Analytical challenges in estimating the effect of exposures that are bounded by follow-up time: experiences from the Blood Stream Infection—Focus on Outcomes study
6. Exposure of Escherichia coli to antibiotic-efflux pump inhibitor combinations in a pharmacokinetic model: impact on bacterial clearance and drug resistance
7. Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms : A White Paper From COMBACTE’s STAT-Net
8. Antibacterial effect of seven days exposure to ceftolozane-tazobactam as monotherapy and in combination with fosfomycin or tobramycin against Pseudomonas aeruginosa with ceftolozane-tazobactam MICs at or above 4 mg/l in an in vitro pharmacokinetic model
9. One- and two-stage surgical revision of peri-prosthetic joint infection of the hip: a pooled individual participant data analysis of 44 cohort studies
10. Pharmacodynamics of minocycline against Acinetobacter baumannii studied in a pharmacokinetic model of infection
11. Modifiable healthcare factors affecting 28-day survival in bloodstream infection: a prospective cohort study
12. The relationship between minimum inhibitory concentration and 28 day mortality in patients with a Gram-negative bloodstream infection: an analysis of data from a cohort study (BSI-FOO)
13. 617. Pharmacodynamics of Ceftolozane-Tazobactam (C/T) as Monotherapy and in Combination with Tobramycin or Fosfomycin Against P.aeruginosa with C/T MICs at or Above 4mg/L
14. A long history of β-lactams for MRSA
15. Predictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infections
16. The effect of duration of therapy for treatment of Staphylococcus aureus blood stream infection: an application of cloning to deal with immortal-time bias in an analysis of data from a cohort study (BSI-FOO)
17. Abstracts from the NIHR INVOLVE Conference 2017: London, UK. 28 November 2017
18. Towards better antimicrobial susceptibility testing: impact of the Journal of Antimicrobial Chemotherapy
19. In vitro Models of Infection: Pharmacokinetic/Pharmacodynamic Correlates
20. The relationship between minimum inhibitory concentration and 28 day mortality in patients with a Gram-negative bloodstream infection: an analysis of data from a cohort study (BSI-FOO).
21. The effect of duration of therapy for treatment of Staphylococcus aureus blood stream infection: an application of cloning to deal with immortal-time bias in an analysis of data from a cohort study (BSI-FOO).
22. Identification and characterisation of Klebsiella pneumoniae and Pseudomonas aeruginosa clinical isolates with atypical β-lactam susceptibility profiles using Orbitrap liquid chromatography-tandem mass spectrometry
23. Comparative bactericidal activity of representative β-lactams against Enterobacterales, Acinetobacter baumannii and Pseudomonas aeruginosa
24. Exploring the Pharmacokinetics of Phenoxymethylpenicillin (Penicillin-V) in Adults: A Healthy Volunteer Study
25. Differences in the pharmacodynamics of ceftaroline against different species of Enterobacteriaceae studied in an in vitro pharmacokinetic model of infection
26. Limited phylogenetic overlap between fluoroquinolone-resistant Escherichia coli isolated on dairy farms and those causing bacteriuria in humans living in the same geographical region
27. Trade-Offs between Antibacterial Resistance and Fitness Cost in the Production of Metallo-β-Lactamases by Enteric Bacteria Manifest as Sporadic Emergence of Carbapenem Resistance in a Clinical Setting
28. Prevalence of antibiotic resistance in Escherichia coli isolated from urine samples routinely referred by general practitioners in a large urban centre in south-west England
29. Patients with transplantation have reduced mortality in bacteraemia: Analysis of data from a randomised trial.
30. Surveillance of Antimicrobial Resistance: Centralised Surveys to Validate Routine Data Offer a Practical Approach
31. Routine Feedback To GPs Who Request Microbiological Tests Is Effective
32. Trade-Offs Between Antibacterial Resistance and Fitness Cost in the Production of Metallo-β-Lactamase by Enteric Bacteria Manifest as Sporadic Emergence of Carbapenem Resistance in a Clinical Setting
33. Oxazolidinones
34. List of Contributors
35. Methodological features of clinical pharmacokinetic–pharmacodynamic studies of antibacterials and antifungals: a systematic review
36. Continuous Infusion of β-Lactam Antibiotics
37. Pharmacodynamics of plazomicin and a comparator aminoglycoside, amikacin, studied in an in vitro pharmacokinetic model of infection
38. Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
39. Comparative antibacterial effects of daptomycin, vancomycin and teicoplanin studied in an in vitro pharmacokinetic model of infection
40. Clinical implications of antimicrobial resistance for therapy
41. Tigecycline pharmacokinetic/pharmacodynamic update
42. Retrospective review of serum teicoplanin concentrations in clinical trials and their relationship to clinical outcome
43. Pharmacodynamics of dalbavancin studied in an in vitro pharmacokinetic system
44. Reduced expression of the atl autolysin gene and susceptibility to autolysis in clinical heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA) and GISA strains
45. Treatment of Gram-positive bone and joint infection: authorsʼ response
46. Antibiotic treatment of Gram-positive bone and joint infections
47. Pharmacodynamics of linezolid in a clinical isolate of Streptococcus pneumoniae genetically modified to express lux genes
48. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria
49. Determination by HPLC of chlortetracycline in pig faeces
50. Development of the quinolones
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.